| Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study EH Martinez-Lapiscina, S Arnow, JA Wilson, S Saidha, JL Preiningerova, ... The Lancet Neurology 15 (6), 574-584, 2016 | 149 | 2016 |
| Dynamics of retinal injury after acute optic neuritis I Gabilondo, EH Martínez‐Lapiscina, E Fraga‐Pumar, S Ortiz‐Perez, ... Annals of neurology 77 (3), 517-528, 2015 | 84 | 2015 |
| Metabolomic signatures associated with disease severity in multiple sclerosis P Villoslada, C Alonso, I Agirrezabal, E Kotelnikova, I Zubizarreta, ... Neurology-Neuroimmunology Neuroinflammation 4 (2), e321, 2017 | 20 | 2017 |
| The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS EH Martínez-Lapiscina, E Fraga-Pumar, I Gabilondo, E Martínez-Heras, ... BMC research notes 7 (1), 910, 2014 | 20 | 2014 |
| Knowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis Ontology A Malhotra, M Gündel, AM Rajput, HT Mevissen, A Saiz, X Pastor, ... PloS one 10 (2), e0116718, 2015 | 19 | 2015 |
| Early retinal atrophy predicts long-term visual impairment after acute optic neuritis B Sanchez-Dalmau, EH Martinez-Lapiscina, R Torres-Torres, ... Multiple Sclerosis Journal 24 (9), 1196-1204, 2018 | 14 | 2018 |
| Tolerogenic dendritic cells as a promising antigen-specific therapy in the treatment of multiple sclerosis and neuromyelitis optica from preclinical to clinical trials G Flórez-Grau, I Zubizarreta, R Cabezón, P Villoslada, D Benitez-Ribas Frontiers in immunology 9, 1169, 2018 | 12 | 2018 |
| Visual field impairment captures disease burden in multiple sclerosis S Ortiz-Perez, M Andorra, B Sanchez-Dalmau, R Torres–Torres, D Calbet, ... Journal of neurology 263 (4), 695-702, 2016 | 12 | 2016 |
| Assessing biological and methodological aspects of brain volume loss in multiple sclerosis M Andorra, K Nakamura, EJ Lampert, I Pulido-Valdeolivas, I Zubizarreta, ... JAMA neurology 75 (10), 1246-1255, 2018 | 9 | 2018 |
| Dynamics and heterogeneity of brain damage in multiple sclerosis E Kotelnikova, NA Kiani, E Abad, EH Martinez-Lapiscina, M Andorra, ... PLoS computational biology 13 (10), e1005757, 2017 | 9 | 2017 |
| Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial I Zubizarreta, G Flórez-Grau, G Vila, R Cabezón, C España, M Andorra, ... Proceedings of the National Academy of Sciences 116 (17), 8463-8470, 2019 | 8 | 2019 |
| Impairment of decision-making in multiple sclerosis: A neuroeconomic approach M Sepúlveda, B Fernández-Diez, EH Martínez-Lapiscina, S Llufriu, ... Multiple Sclerosis Journal 23 (13), 1762-1771, 2017 | 8 | 2017 |
| Predictors of vision impairment in multiple sclerosis B Sanchez-Dalmau, EH Martinez-Lapiscina, I Pulido-Valdeolivas, ... PloS one 13 (4), e0195856, 2018 | 5 | 2018 |
| The analysis of semantic networks in multiple sclerosis identifies preferential damage of long-range connectivity E Abad, J Sepulcre, EH Martinez-Lapiscina, I Zubizarreta, J Garcia-Ojalvo, ... Multiple sclerosis and related disorders 4 (5), 387-394, 2015 | 5 | 2015 |
| Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis E Solana, E Martinez-Heras, EH Martinez-Lapiscina, M Sepulveda, ... NeuroImage: Clinical 20, 161-168, 2018 | 4 | 2018 |
| Precision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision making I Pulido-Valdeolivas, I Zubizarreta, EH Martinez-Lapiscina, P Villoslada Expert Review of Precision Medicine and Drug Development 2 (6), 345-361, 2017 | 4 | 2017 |
| Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis N Solà-Valls, M Vicente-Pascual, Y Blanco, E Solana, S Llufriu, ... Multiple sclerosis and related disorders 27, 333-339, 2019 | 2 | 2019 |
| Systems medicine modeling for multiple sclerosis E Kotelnikova, I Zubizarreta, I Pulido-Valdeolivas, P Villoslada Current Opinion in Systems Biology 3, 125-131, 2017 | 2 | 2017 |
| Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors M Sepúlveda, C Montejo, S Llufriu, N Sola-Valls, D Reyes, ... Multiple sclerosis and related disorders 38, 101483, 2020 | | 2020 |
| Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis M Andorrà, S Alba-Arbalat, A Camos-Carreras, I Gabilondo, ... JAMA neurology, 2019 | | 2019 |
